Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites: Technical considerations and results

Strahlentherapie und Onkologie

Volumn 183, Issue 8, 2007, Pages 411-416

  Hata, Masaharu ^a,b,c   Tokuuye, Koichi ^a,b   Sugahara, Shinji ^b   Tohno, Eriko ^b   Fukumitsu, Nobuyoshi ^a,b   Hashimoto, Takayuki ^a,b   Ohnishi, Kayoko ^b   Nemoto, Keiko ^b   Ohara, Kiyoshi ^b   Sakae, Takeji ^a   Akine, Yasuyuki ^a,b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ascites; Hepatocellular carcinoma; Proton beam therapy; Radiation therapy; Single fraction irradiation

Indexed keywords

AGED; ARTICLE; ASCITES TUMOR; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS RUPTURE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LYMPH NODE; MALE; PROTON RADIATION; PROTON THERAPY; TUMOR VOLUME;

AGED; ASCITES; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; PROTONS; RADIOTHERAPY, HIGH-ENERGY; RECURRENCE; TREATMENT OUTCOME;

EID: 34547777895     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1640-2     Document Type: Article

References (33)

1. Ando K, Koike S, Kawachi K, et al. Relative biological effectiveness of the therapeutic proton beam at NIRS and Tsukuba University. Nippon Acta Radiol 1985;45:531-5.
2. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-9.
3. Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70.
4. Chiba T, Tokuuye K, Matsuzaki Y, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005;11:3799-805.
5. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Bethesda, Md., USA: National Cancer Institute, 2006 (http://ctep.cancer.gov/reporting/ ctc.html, accessed August 1, 2006).
6. Cozzi L, Clivio A, Vanetti E, et al. Comparative planning study for proton radiotherapy of benign brain tumors. Strahlenther Onkol 2006;182:376-81.
7. Dawson LA, Ten Hakken RK, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol 2001;11:240-6.
8. Greco C, Catalano G, Grazia AD, et al. Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy. Tumori 2004;90:73-9.
9. Hashimoto T, Tokuuye K, Fukumitsu N, et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;65:196-202.
10. Hata M, Tokuuye K, Sugahara S, et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2005;104:794-801.
11. Hata M, Tokuuye K, Sugahara S, et al. Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer 2006;107:591-8.
12. Hata M, Tokuuye K, Sugahara S, et al. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol 2006;182:713-20.
13. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19:164-70.
14. Höcht S, Stark R, Seiler F, et al. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison. Strahlenther Onkol 2005;181:783-8.
15. Hsu C, Cheng JC, Cheng AL. Recent advances in non-surgical treatment for advanced hepatocellular carcinoma. J Formos Med Assoc 2004;103:483-95.
16. Lawrence TS, Ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992;23:781-8.
17. Lee HM, Lu DS, Krasny RM, et al. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR Am J Roentgenol 1997;169:125-30.
18. Liang SX, Zhu XD, Lu HJ, et al. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma. Cancer 2005;103:2181-8.
19. Lim JH, Choi D, Kim SH, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002;179:67-73.
20. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005;40:225-35.
21. Marnitz S, Cordini D, Bendl R, et al. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning. Strahlenther Onkol 2006;182:395-9.
22. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19:3-23.
23. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma. Strahlenther Onkol 2005;181:448-55.
24. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
25. Proton Medical Research Center, University of Tsukuba. Patient statistics. Tsukuba: Proton Medical Research Center, 2006 (http://www.pmrc. tsukuba.ac.jp/EN/index.html, accessed August 1, 2006).
26. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
27. Rutz HP, Lomax AJ. Donut-shaped high-dose configuration for proton beam radiation therapy. Strahlenther Onkol 2004;181:49-53.
28. Suit H, Goldberg S, Niemierko A, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 2003;42:800-8.
29. Tokuuye K, Akine Y, Kagei K, et al. Proton therapy for head and heck malignancies at Tsukuba. Strahlenther Onkol 2004;180:96-101.
30. Tsunashima Y, Sakae T, Shioyama Y, et al. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:951-8.
31. Wada H, Takai Y, Nemoto K, et al. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004;58:1114-20.
32. Withers HR, Thames HD Jr, Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol 1983;1:187-91.
33. Wulf J, Hädinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Oncol 2001;177:645-55.